Role of matrix metalloproteinases in joint destruction in rheumatoid arthritis

Role of matrix metalloproteinases in joint destruction in rheumatoid arthritis

Bibliographic Details
Main Author:	R. Y. Kashevarov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2004-08-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/941

Similar Items

Matrix Metalloproteinase-9 Level in Synovial Fluid—Association with Joint Destruction in Early Rheumatoid Arthritis
by: Sonja K. Stojanovic, et al.
Published: (2023-01-01)

Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
by: Murphy, G, et al.
Published: (2008)

Role of LIGHT in the pathogenesis of joint destruction in rheumatoid arthritis
by: Sabokbar, A, et al.
Published: (2017)

Progression of joint destruction in patients with rheumatoid arthritis
by: Olga Yuryevna Vakulenko, et al.
Published: (2011-06-01)

Immunomodulatory roles of metalloproteinases in rheumatoid arthritis
by: Yanqin Bian, et al.
Published: (2023-11-01)

Serum matrix metalloproteinase-3 predicts radiographic joint damage and functional disability in rheumatoid arthritis
by: Sakthiswary Rajalingham,, et al.
Published: (2016)

Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
by: Jain, A, et al.
Published: (2001)

The role of matrix metalloproteinases in rheumatoid tendon disease.
by: Jain, A, et al.
Published: (2002)

Matrix metalloproteinases in rheumatoid arthritis and osteoarthritis: a state of the art review
by: Łukasz Pulik, et al.
Published: (2023-07-01)

New Insights into the Role of Synovial Fibroblasts Leading to Joint Destruction in Rheumatoid Arthritis
by: Kotaro Matsuda, et al.
Published: (2023-03-01)

ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: A. S. Avdeeva, et al.
Published: (2016-03-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2013-06-01)

Matrix metalloproteinase 2, 3, and 9 gene polymorphisms in women with rheumatoid arthritis
by: A V Shevchenko, et al.
Published: (2015-12-01)

The role of monitoring the level of matrix metalloproteinase 3 in patients with rheumatoid arthritis on anti-B-cell therapy
by: A. S. Avdeeva, et al.
Published: (2022-09-01)

Study of Effective Factors on Insulin Sensitivity and Matrix Metalloproteinase in Women with Rheumatoid Arthritis
by: Rasoul Sharifi, et al.
Published: (2018-10-01)

Influence of disease activity and treatment on rate of joint destruction in rheumatoid arthritis
by: D V Goryachev, et al.
Published: (2008-10-01)

The effect of long non-coding RNAs in joint destruction of rheumatoid arthritis
by: Hanxiao Zhao, et al.
Published: (2022-10-01)

Factors associated with hand joint destruction in Chinese patients with rheumatoid arthritis
by: Lijuan Zhang, et al.
Published: (2017-05-01)

Serum and synovial matrix metalloproteinase-3 as markers of disease activity in early rheumatoid arthritis
by: Rasha M Fawzy, et al.
Published: (2016-01-01)

Roles of MicroRNAs in Bone Destruction of Rheumatoid Arthritis
by: Hanxiao Zhao, et al.
Published: (2020-11-01)

MARKERS OF SEVERE DESTRUCTION RHEUMATOID ARTHRITIS
by: E. B. Komarova
Published: (2017-12-01)

THE CLINICAL SIGNIFICANCE OF MATRIX METALLOPROTEINASES IN RHEUMATOID ARTHRITIS PATIENTS (REVIEW OF THE LITERATURE AND OUR OWN DATA)
by: Anastasiya S Avdeeva, et al.
Published: (2014-03-01)

Erratum to: Factors associated with hand joint destruction in Chinese patients with rheumatoid arthritis
by: Lijuan Zhang, et al.
Published: (2017-05-01)

Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis
by: Sai Krishna Srimadh Bhagavatham, et al.
Published: (2021-07-01)

Matrix metalloproteinase-3 and the 7-joint ultrasound score in the assessment of disease activity and therapeutic efficacy in patients with moderate to severe rheumatoid arthritis
by: Ling Zhou, et al.
Published: (2017-11-01)

Serum matrix metalloproteinase-3 levels monitor the therapeutic efficacy in Syrian patients with rheumatoid arthritis
by: Rama Hussein, et al.
Published: (2023-03-01)

Evaluation of the immune feature of ACPA-negative rheumatoid arthritis and the clinical value of matrix metalloproteinase-3
by: Zhaojun Liang, et al.
Published: (2022-07-01)

Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.
by: Miller, M, et al.
Published: (2009)

SYSTEM OF MATRIX METALLOPROTEINASES IN THE EVALUATION OF LUNG TISSUE DESTRUCTION IN TUBERCULOSIS
by: D. S. Esmedlyaeva, et al.
Published: (2015-08-01)

Bilateral septic arthritis with rapid progressive destruction of the femoral head after joint injection in rheumatoid arthritis
by: V. Freigang, et al.
Published: (2021-07-01)

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy.
by: Brennan, F, et al.
Published: (1997)

Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis
by: A S Avdeeva, et al.
Published: (2013-05-01)

Serum and synovial matrix metalloproteinases 1 and 3 in patients with early rheumatoid arthritis: potentially prospective biomarkers of ultrasonographic joint damage and disease activity
by: Maryam A. Abdelrahman, et al.
Published: (2019-01-01)

Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments
by: Kazuhiro Maeda, et al.
Published: (2022-03-01)

RANK+TLR2+ myeloid subpopulation converts autoimmune to joint destruction in rheumatoid arthritis
by: Weixin Zhang, et al.
Published: (2023-05-01)

Assessment of large joint destruction in patients with rheumatoid arthritis using FDG-PET/CT
by: Takahito Suto, et al.
Published: (2016-10-01)

Comparison between the roles of musculoskeletal ultrasound and magnetic resonance imaging in detection of joint inflammation and destruction in rheumatoid arthritis
by: Sherihan M Salama
Published: (2019-01-01)

Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies
by: Itoh, Y
Published: (2017)

Variation in the matrix metalloproteinase-3, -7, -12 and -13 genes is associated with functional status in rheumatoid arthritis.
by: Ye, S, et al.
Published: (2007)

Low doses glucocorticoid effect on joint destruction and mineral bone density in early rheumatoid arthritis
by: E V Suponitskaya
Published: (2003-08-01)